Sofia Buch Email
CEO @ ArgusEye
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Sofia Buch Location
- Copenhagen, DK
Sofia Buch Work
- CEO @ (April 2026 - Present)
- Strategic Advisor @ (November 2025 - Present)
- Vice President for Cell Therapy CMC at Novo Nordisk @ (July 2021 - April 2026)
- Vice President for Stem Cell CMC and Manufacturing @ (September 2018 - July 2021)
- Project Vice President for stem cell projects @ (November 2017 - February 2019)
- Vice President for Recombinant Technologies @ (August 2015 - November 2017)
- Vice President for Yeast Protein Technology @ (September 2014 - August 2015)
- Senior Director for Protein Chemistry @ (February 2013 - September 2014)
- Project Director @ (February 2013 - September 2014)
- Director @ (August 2011 - February 2013)
- Team leader @ (October 2010 - August 2011)
- Research Scientist @ (July 2006 - October 2010)
Sofia Buch Education
- Linköping University
Doctor of Philosophy (Ph.D.) (Molecular Biotechnology)
2000-2005 - Linköping University
Master of Science (M.Sc.) (Chemistry)
1996-2000
Sofia Buch Skills
- Biochemistry
- CMC development
- Cell Therapy
- Drug Discovery
- Executive Advisory
- HPLC
- LC-MS
- Mass Spectrometry
- Protein Chemistry
- Protein Purification
- Stem Cells
- Strategic Planning
- Biotechnology
- Business Development
- Project Planning
- Lc Ms
Sofia Buch Summary
- Sofia Buch, based in Copenhagen, DK, is currently a CEO at ArgusEye. Sofia Buch brings experience from previous roles at Nordic Cell Therapy Group and Novo Nordisk. Sofia Buch holds a 2000 - 2005 Doctor of Philosophy (Ph.D.) in Molecular Biotechnology @ Linköping University. With a robust skill set that includes Biochemistry, CMC development, Cell Therapy, Drug Discovery, Executive Advisory and more. Sofia Buch has 1 emails on RocketReach.
Looking for a different Sofia Buch?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co